Literature DB >> 22134774

Suitability of initial antibiotic therapy for the treatment of bloodstream infections and the potential role of antibiotic management teams in improving it.

S Diamantis1, C Rioux, C Bonnal, É Farfour, E Papy, A Andremont, P Yeni, É Bouvet, J-C Lucet.   

Abstract

Hospital antibiotic management teams (AMTs) have been recommended, but, in France, their concrete implementation remains scarce and their effectiveness largely unevaluated. The objective of this investigation was to evaluate the appropriateness of antibiotic therapy (AT) for bloodstream infections (BSIs) at a 950-bed university teaching hospital, and assess the role of an AMT in improving it. A prospective analysis of all significant BSIs occurring outside of the intensive care unit (ICU) during an 18-month period was carried out. AT was deemed effective if at least one prescribed antibiotic was effective in vitro, and appropriate if it was consistent with local recommendations. Out of 574 BSIs, 512 were evaluated: 231 community-acquired, 206 nosocomial, and 75 healthcare-associated. For 219 (42.8%) BSIs, the AT initiated prior to AMT intervention proved to be effective and appropriate, inappropriate but effective in 136 (26.5%), and ineffective or absent in 157 (30.7%). In the multivariate analysis, hospital-acquired and other healthcare-associated BSIs, as well as catheter-borne (CB) infections, were associated with inappropriate or absent AT. A recommendation from the AMT was given and followed in 233 (94%) out of 249 BSIs requiring intervention. Initially, two-thirds of BSIs outside the ICU did not receive appropriate AT. Healthcare-associated BSIs should, therefore, be the priority target of AMTs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22134774     DOI: 10.1007/s10096-011-1491-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia.

Authors:  B Byl; P Clevenbergh; F Jacobs; M J Struelens; F Zech; A Kentos; J P Thys
Journal:  Clin Infect Dis       Date:  1999-07       Impact factor: 9.079

Review 2.  Antimicrobial stewardship programs in health care systems.

Authors:  Conan MacDougall; Ron E Polk
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

3.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

4.  Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Ben M Lomaestro; John C Rotschafer; Robert C Moellering; Willam A Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

5.  Infectious diseases consultation: impact on outcomes for hospitalized patients and results of a preliminary study.

Authors:  D C Classen; J P Burke; R P Wenzel
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

6.  Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients.

Authors:  B Renaud; C Brun-Buisson
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

7.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

8.  The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection.

Authors:  L Leibovici; I Shraga; M Drucker; H Konigsberger; Z Samra; S D Pitlik
Journal:  J Intern Med       Date:  1998-11       Impact factor: 8.989

9.  Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients.

Authors:  V G Fowler; L L Sanders; D J Sexton; L Kong; K A Marr; A K Gopal; G Gottlieb; R S McClelland; G R Corey
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

10.  Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes.

Authors:  S L Pestotnik; D C Classen; R S Evans; J P Burke
Journal:  Ann Intern Med       Date:  1996-05-15       Impact factor: 25.391

View more
  3 in total

1.  Blood Culture Turnaround Time in U.S. Acute Care Hospitals and Implications for Laboratory Process Optimization.

Authors:  Ying P Tabak; Latha Vankeepuram; Gang Ye; Kay Jeffers; Vikas Gupta; Patrick R Murray
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

2.  A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections.

Authors:  R Murri; F Taccari; T Spanu; T D'Inzeo; I Mastrorosa; F Giovannenze; G Scoppettuolo; G Ventura; C Palazzolo; M Camici; S Lardo; B Fiori; M Sanguinetti; R Cauda; M Fantoni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-19       Impact factor: 3.267

3.  Appropriateness of Empirical Fluoroquinolones Therapy in Patients Infected with Escherichia coli, Klebsiella pneumoniae, or Pseudomonas aeruginosa: The Importance of the CLSI Breakpoints Revision.

Authors:  Ying Wang; Xinping Zhang; Xuemei Wang; Xiaoquan Lai
Journal:  Infect Drug Resist       Date:  2021-08-31       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.